AI assistant
BIO-TECHNE Corp — Director's Dealing 2025
Jun 11, 2025
30718_dirs_2025-06-11_331c22dd-8b8f-4cc3-a48f-2a7ea3ecea7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-06-09
Reporting Person: Herr Amy E. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-09 | Common Stock | M | 1280 | $44.33 | Acquired | 3256 | Indirect |
| 2025-06-09 | Common Stock | S | 1280 | $49.7694 | Disposed | 1976 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | Stock Option (Right to Buy) | $44.33 | M | 1280 | Disposed | 2025-08-08 | Common Stock (1280) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1040 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (2415) | 2415 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (6636) | 6636 | Indirect |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (4472) | 4472 | Indirect |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (2076) | 2076 | Indirect |
| Stock Option (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (2104) | 2104 | Indirect |
| Stock Option (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (1084) | 1084 | Indirect |
| Stock Option (Right to Buy) | $74.91 | 2034-08-15 | Common Stock (1468) | 1468 | Indirect |
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (344) | 344 | Indirect |
| Restricted Stock Units | $ | Common Stock (237) | 237 | Indirect | |
| Restricted Stock Units | $ | Common Stock (480) | 480 | Indirect | |
| Restricted Stock Units | $ | Common Stock (115) | 115 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 49.7471 to 49.8100, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.
F3: Fully vested.
F4: 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
F5: 528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
F6: 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
F7: 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F8: 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
F9: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F10: 119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
F11: 160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
F12: 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.